About University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD
УМБАЛ „Царица Йоанна – ИСУЛ“ или както е известна ИСУЛ е университетска многопрофилна болница за активно лечение, намираща се в София, с адрес ул. Бяло море 8, Телефон: 02 9432170. Болницата е висок капацитет за обслужване на пациенти по спешност и на диагностично и терапевтично трудни случаи.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
6
Celgene
6
Shire
5
Amgen
4
Hoffmann-La Roche
3
Biolex Therapeutics, Inc.
2
Ferring Pharmaceuticals
2
Helsinn Healthcare SA
2
Bial - Portela C S.A.
1
Inventiva Pharma
1
Pfizer
1
Clinical Trials at University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD
During the past decade, University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 15 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV
2009-03-01
2011-11-01
Completed
116
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)
2009-07-01
2011-01-01
Completed
74
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
2011-07-01
2012-11-01
Completed
743
Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients
2010-04-01
2013-09-01
Completed
72
Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
2012-12-26
2019-08-30
Completed
199
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
2013-12-03
2017-04-13
Completed
1,320
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" #1 sponsor was "Bayer" with 6 trials, followed by "Celgene" with 6 trials
sponsored, "Shire" with 5 trials sponsored, "Amgen" with 4 trials sponsored and "Hoffmann-La Roche"
with 4 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD"
#1 collaborator was "Parexel" with 2 trials as a collaborator, "Innovative Therapies For Children with Cancer Consortium" with 1 trials as a collaborator and "Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD
According to Clinical.Site data, the most researched conditions in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" are
"Ulcerative Colitis" (7 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Heart Failure" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" in a lesser frequency.
Clinical Trials Intervention Types at University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD
Most popular intervention types in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" are "Drug" (31 trials), "Other" (8 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Ozanimod" (6 trials), "Ontamalimab" (4 trials), "Dexamethasone" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD
The vast majority of trials in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD" are
33 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD
Currently, there are NaN active trials in "University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD".
undefined are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD, 1 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".